These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

492 related articles for article (PubMed ID: 35313877)

  • 1. High fibrinogen-to-albumin ratio with type 2 diabetes mellitus is associated with poor prognosis in patients undergoing percutaneous coronary intervention: 5-year findings from a large cohort.
    Wang P; Yuan D; Zhang C; Zhu P; Jia S; Song Y; Tang X; Xu J; Li T; Zeng G; Zhao X; Yang Y; Xu B; Gao R; Yuan J
    Cardiovasc Diabetol; 2022 Mar; 21(1):46. PubMed ID: 35313877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High neutrophil to lymphocyte ratio with type 2 diabetes mellitus predicts poor prognosis in patients undergoing percutaneous coronary intervention: a large-scale cohort study.
    He J; Bian X; Song C; Zhang R; Yuan S; Yin D; Dou K
    Cardiovasc Diabetol; 2022 Aug; 21(1):156. PubMed ID: 35964050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of fibrinogen in patients with coronary artery disease and prediabetes or diabetes following percutaneous coronary intervention: 5-year findings from a large cohort study.
    Yuan D; Jiang P; Zhu P; Jia S; Zhang C; Liu Y; Liu R; Xu J; Tang X; Zhao X; Gao R; Yang Y; Xu B; Gao Z; Yuan J
    Cardiovasc Diabetol; 2021 Jul; 20(1):143. PubMed ID: 34271936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of fibrinogen-to-albumin ratio combined with coronary calcification score in patients with suspected coronary artery disease.
    Tian XX; Luo JY; Liu F; Qiu YJ; Luo F; Zeng L; Zhang ZR; Yang YN; Li XM
    BMC Cardiovasc Disord; 2023 Apr; 23(1):181. PubMed ID: 37016312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The atherogenic index of plasma plays an important role in predicting the prognosis of type 2 diabetic subjects undergoing percutaneous coronary intervention: results from an observational cohort study in China.
    Qin Z; Zhou K; Li Y; Cheng W; Wang Z; Wang J; Gao F; Yang L; Xu Y; Wu Y; He H; Zhou Y
    Cardiovasc Diabetol; 2020 Feb; 19(1):23. PubMed ID: 32085772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetes mellitus with mild or moderate kidney dysfunction is associated with poor prognosis in patients with coronary artery disease: A large-scale cohort study.
    He J; Song C; Wang H; Zhang R; Yuan S; Dou K
    Diabetes Res Clin Pract; 2023 Jun; 200():110693. PubMed ID: 37160234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of body mass index on long-term outcomes in patients undergoing percutaneous coronary intervention stratified by diabetes mellitus: a retrospective cohort study.
    Rao C; Zhong Q; Wu R; Li Z; Duan Y; Zhou Y; Wang C; Chen X; Wang R; He K
    BMC Cardiovasc Disord; 2024 Feb; 24(1):113. PubMed ID: 38365597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Fibrinogen-to-Albumin Ratio Is Associated With Outcomes in Patients With Coronary Artery Disease Who Underwent Percutaneous Coronary Intervention.
    Zhang DP; Mao XF; Wu TT; Chen Y; Hou XG; Yang Y; Ma X; Zhang JY; Ma YT; Xie X; Zheng YY
    Clin Appl Thromb Hemost; 2020; 26():1076029620933008. PubMed ID: 32598182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of diabetes mellitus status in patients undergoing percutaneous left main coronary artery intervention.
    Roumeliotis A; Siasos G; Dangas G; Power D; Sartori S; Vavouranakis M; Tsioufis K; Leone PP; Vogel B; Cao D; Oliva A; Oikonomou E; Smith KF; Sweeny J; Krishnan P; Kini A; Sharma S; Mehran R
    Catheter Cardiovasc Interv; 2024 Oct; 104(4):723-732. PubMed ID: 39152795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential Impact of Type 1 and Type 2 Diabetes Mellitus on Outcomes Among 1.4 Million US Patients Undergoing Percutaneous Coronary Intervention.
    Matetic A; Doolub G; Bharadwaj A; Osman M; Biondi-Zoccai G; Ullah W; Bagur R; Velagapudi P; Alraies MC; Mohamed MO; Mamas MA
    Cardiovasc Revasc Med; 2022 May; 38():83-88. PubMed ID: 34446373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mortality after percutaneous coronary revascularization: Prior cardiovascular risk factor control and improved outcomes in patients with diabetes mellitus.
    Noman A; Balasubramaniam K; Alhous MHA; Lee K; Jesudason P; Rashid M; Mamas MA; Zaman AG
    Catheter Cardiovasc Interv; 2017 Jun; 89(7):1195-1204. PubMed ID: 28029209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Baseline plasma fibrinogen is associated with haemoglobin A1c and 2-year major adverse cardiovascular events following percutaneous coronary intervention in patients with acute coronary syndrome: a single-centre, prospective cohort study.
    Zhang L; Xu C; Liu J; Bai X; Li R; Wang L; Zhou J; Wu Y; Yuan Z
    Cardiovasc Diabetol; 2019 Apr; 18(1):52. PubMed ID: 31014348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Fibrinogen-to-Albumin Ratio Is Associated with Poor Prognosis in Patients with Coronary Artery Disease: Findings from a Large Cohort.
    Hou XG; Wu TT; Zheng YY; Yang HT; Yang Y; Ma YT; Xie X
    J Cardiovasc Transl Res; 2023 Oct; 16(5):1177-1183. PubMed ID: 37349658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of 3-dimensional bifurcation angle on 5-year outcome of patients after percutaneous coronary intervention for left main coronary artery disease: a substudy of the SYNTAX trial (synergy between percutaneous coronary intervention with taxus and cardiac surgery).
    Girasis C; Farooq V; Diletti R; Muramatsu T; Bourantas CV; Onuma Y; Holmes DR; Feldman TE; Morel MA; van Es GA; Dawkins KD; Morice MC; Serruys PW
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1250-60. PubMed ID: 24355115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic impact of malnutrition on cardiovascular events in coronary artery disease patients with myocardial damage.
    Arikawa R; Kanda D; Ikeda Y; Tokushige A; Sonoda T; Anzaki K; Ohishi M
    BMC Cardiovasc Disord; 2021 Oct; 21(1):479. PubMed ID: 34615478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Duration of Diabetes Mellitus on Long-Term Outcome in Type 2 Diabetic Patients with Primary Percutaneous Coronary Intervention after the First Myocardial Infarction.
    Yaliqin N; Aimaier S; Adi D; Ma YT; Yu ZX
    Cardiology; 2024; 149(4):297-313. PubMed ID: 38763137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of various insulin resistance surrogates on prognostic prediction and stratification following percutaneous coronary intervention in patients with and without type 2 diabetes mellitus.
    Zhao Q; Cheng YJ; Xu YK; Zhao ZW; Liu C; Sun TN; Zhou YJ
    Cardiovasc Diabetol; 2021 Sep; 20(1):190. PubMed ID: 34537077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High triglyceride-glucose index is associated with poor cardiovascular outcomes in Chinese acute coronary syndrome patients without diabetes mellitus who underwent emergency percutaneous coronary intervention with drug-eluting stents.
    Zhang Y; Chu C; Zhong Z; Luo YB; Ning FF; Guo N
    Front Endocrinol (Lausanne); 2023; 14():1101952. PubMed ID: 36875470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of the glycated hemoglobin levels and prognostic nutritional index as a prognostic marker in patients with acute coronary syndrome and type 2 diabetes mellitus.
    Sun S; Wang Y; Pang S; Wu X
    Lipids Health Dis; 2024 Jan; 23(1):12. PubMed ID: 38212760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association between fibrinogen-to-albumin ratio (FAR) and adverse prognosis in patients with acute decompensated heart failure at different glucose metabolic states.
    Huang R; Dai Q; Chang L; Wang Z; Chen J; Gu R; Zheng H; Hu L; Xu B; Wang L
    Cardiovasc Diabetol; 2022 Nov; 21(1):241. PubMed ID: 36371183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.